| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/12/2004 | US20040156789 Delivery of antihistamines through an inhalation route |
| 08/12/2004 | US20040156788 Delivery of erectile dysfunction drugs through an inhalation route |
| 08/12/2004 | US20040156783 Complexes of cyanine, indocyanine, phthalocyanine, rhodamine, oxazine, thiazine, phenoselenazines, fluoresceins, porphyrin, squaraine, corrins, croconium, azo, methine and/or indolenium dye linked with receptor binding molecules; tumors |
| 08/12/2004 | CA2514934A1 Methods of identifying and designing cell surface receptor inhibitors |
| 08/12/2004 | CA2514659A1 New strains of bifidobacterium having the ability to produce glutamine |
| 08/12/2004 | CA2514653A1 Uses of integrin alphavbeta3 antagonists |
| 08/12/2004 | CA2514581A1 Methods of treating lower urinary tract disorders using sodium channel modulators |
| 08/12/2004 | CA2514580A1 Compositions and methods of tolerizing a primate to an antigen |
| 08/12/2004 | CA2514574A1 Use of sodium channel modulators for treating gastrointestinal tract disorders |
| 08/12/2004 | CA2514560A1 Composition for preventive treatment of cold sores |
| 08/12/2004 | CA2514396A1 Compositions and methods containing substituted quinolines and substituted diphenylsulfones |
| 08/12/2004 | CA2514327A1 Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin |
| 08/12/2004 | CA2514125A1 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/12/2004 | CA2514117A1 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/12/2004 | CA2514066A1 Sensitive proteasome sensor constructs and methods for their design and use |
| 08/12/2004 | CA2512879A1 N-cyclohexylaminocarbonyl benzenesulfonamide derivatives |
| 08/12/2004 | CA2509807A1 Powder pharmaceutical compositions |
| 08/12/2004 | CA2453809A1 Amino acid loaded trityl alcohol resins, method of production of amino acid loaded trityl alcohol resins, and biologically active substances and therapeutics produced therewith |
| 08/11/2004 | EP1444991A1 Novel targeted compositions for diagnostic and therapeutic use |
| 08/11/2004 | EP1444989A1 Sensitizing cells for apoptosis by selectively blocking cytokines |
| 08/11/2004 | EP1444988A1 Anticancer agents |
| 08/11/2004 | EP1444523A2 Screening for hepatitis c virus entry inhibitors |
| 08/11/2004 | EP1444520A2 Methods for monitoring amyotrophic lateral sclerosis |
| 08/11/2004 | EP1444516A2 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 08/11/2004 | EP1444267A2 Affinity enhancement agents |
| 08/11/2004 | EP1444259A2 Adenylate cyclase with additional ion channel domain |
| 08/11/2004 | EP1444254A2 Molecules for disease detection and treatment |
| 08/11/2004 | EP1444235A1 Reverse-turn mimetics and method relating thereto |
| 08/11/2004 | EP1444229A1 Pyrazole derivatives as psychopharmaceuticals |
| 08/11/2004 | EP1444223A1 Aminopyrimidines and -pyridines |
| 08/11/2004 | EP1444220A1 Compounds and method for the treatment of overactive bladder |
| 08/11/2004 | EP1444204A1 Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them |
| 08/11/2004 | EP1444203A1 Cannabinoid receptor ligands |
| 08/11/2004 | EP1444200A1 Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1 |
| 08/11/2004 | EP1444009A1 Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors |
| 08/11/2004 | EP1443970A2 Promoters exhibiting endothelial cell specificity and methods of using same |
| 08/11/2004 | EP1443969A2 Non-inclusion cyclodextrin complexes |
| 08/11/2004 | EP1443967A1 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 08/11/2004 | EP1443966A1 Method of preventing or treating benign gynaecological disorders |
| 08/11/2004 | EP1443956A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
| 08/11/2004 | EP1443953A2 Detection and treatment of intravascular lesions |
| 08/11/2004 | EP1443950A2 A plant extract active as an immunostimulating agent |
| 08/11/2004 | EP1443942A1 Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol |
| 08/11/2004 | EP1443939A1 Compositions for treatment of postmenopausal female sexual dysfunction |
| 08/11/2004 | EP1443933A2 Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents |
| 08/11/2004 | EP1443929A2 Treatment of cns disorders using cns target modulators |
| 08/11/2004 | EP1443923A1 Hydroxy substituted amides for the treatment of alzheimer's disease |
| 08/11/2004 | EP1443922A1 Mch antagonists for the treatment of obesity |
| 08/11/2004 | EP1443920A2 Preparation for improving the action of receptors |
| 08/11/2004 | EP1443919A1 Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein |
| 08/11/2004 | EP1443916A1 Pharmaceutical composition comprising an adenosine a1/a2 agonist and a sodium hydrogen exchanger inhibitor |
| 08/11/2004 | EP1443915A1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 08/11/2004 | EP1443913A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/11/2004 | EP1443904A2 Orally administered pharmaceutical preparation comprising liposomically encapsulated paclitaxel |
| 08/11/2004 | EP1443903A2 Proliposomal drug delivery system |
| 08/11/2004 | EP1443899A2 Bowel cleansing agent |
| 08/11/2004 | EP1443816A2 Methods of treating disorders related to apoe |
| 08/11/2004 | EP1363677A4 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing |
| 08/11/2004 | EP1225904B1 Combinations of lamivudine and entecavir for treatment of hepatitis b virus infection |
| 08/11/2004 | EP1154988B1 Mevinolin derivatives |
| 08/11/2004 | EP1131105B1 Complexes of hyaluronic acid/carnitines and pharmaceutical and cosmetic compositions |
| 08/11/2004 | EP1059939B1 Apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
| 08/11/2004 | EP1051187B9 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway |
| 08/11/2004 | EP1028732B1 Use of selected phytostenol esters for producing hypocholesteraemic preparations |
| 08/11/2004 | EP1012329A4 Diagnosis and treatment of myocardial failure |
| 08/11/2004 | EP0852491B1 Use of heparinases to decrease inflammatory responses |
| 08/11/2004 | EP0821728B1 Tie-2 ligands, methods of making and uses thereof |
| 08/11/2004 | EP0730648B1 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER |
| 08/11/2004 | EP0575464B1 Modified factor vii |
| 08/11/2004 | CN1520437A Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug |
| 08/11/2004 | CN1520401A Calcilytic compounds |
| 08/11/2004 | CN1520324A Antiangiogenic combination thereapy for treatment of cancer |
| 08/11/2004 | CN1520320A Method of intradermally injecting substances |
| 08/11/2004 | CN1520314A Drugs contg. chymase inhibitor and ace inhibitors as active ingredients |
| 08/11/2004 | CN1520311A Cancer vaccine contg. cancer antigen based on tumor suppressor gene WT1 product and cationic liposomes |
| 08/11/2004 | CN1520310A Use of angiotensin derivative as agent for treatment and prevention of infarction-related cardiac injuries and disorders |
| 08/11/2004 | CN1520309A Methods and compsns. for treating oral and eosophagal lesions |
| 08/11/2004 | CN1520306A Methods and devices for tissure repair |
| 08/11/2004 | CN1520302A Method of treating hyperproliferative diseases using active vitamin D analogues |
| 08/11/2004 | CN1520301A Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
| 08/11/2004 | CN1520300A Dihydro-triterpenes in treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 08/11/2004 | CN1520299A Use of compounds with combined NEP/MP-inbihitory activity in prepan. of medicaments |
| 08/11/2004 | CN1520298A Pyrazolopyrimidines as therapeutic agents |
| 08/11/2004 | CN1520297A Sustained release drug delivery system contg. codrugs |
| 08/11/2004 | CN1520295A Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 08/11/2004 | CN1520288A Methods for prepn. and use of 1alpha, 24 (S)-dihydroxyvitamin D2 |
| 08/11/2004 | CN1520284A Anorexic compsn. comprising calcium acetate |
| 08/11/2004 | CN1520281A Compsn. for treatment of burns |
| 08/11/2004 | CN1161396C Biodegradable low molecular weight triblock polyester polyethylene glocol copolymers having reverse thermal gelation properties |
| 08/11/2004 | CN1161355C New compounds |
| 08/11/2004 | CN1161152C Method and composition useful for inhibition of angiogenesis |
| 08/11/2004 | CN1161127C Cross-linked polysaccharide drug carrier |
| 08/11/2004 | CN1161118C Use of 5HT3 receptor antagouists for the treatment of chronic fatigue syndrome |
| 08/11/2004 | CN1161116C Use of L-Carnitine and derviatives for reducing ceramide levels and potentiating antiretroviral |
| 08/11/2004 | CN1161113C Methods for treatment of neuro-and nephro-disorders and therapeutic toxicities using aminothiol compounds |
| 08/11/2004 | CN1161036C Compsns. containing creatine in suspension |
| 08/10/2004 | US6774227 Reating disorders related to cellular overproliferation comprising neutralizing the production or activity of macrophage migration inhibitory factor (mif) |
| 08/10/2004 | US6774209 Synthetic, isolated polypeptides overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon; for imaging |
| 08/10/2004 | US6774128 Administering to the mammal a therapeutically effective amount of a compound that increases nitric oxide (no) activity as measured in a standard gastric emptying assay |
| 08/10/2004 | US6774124 Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions |